Breaking News

Medix Biochemica Acquires Candor Bioscience

Expands its offering of critical IVD raw materials and enhances its capabilities to support test manufacturers in immunoassay development.

Author Image

By: Charlie Sternberg

Associate Editor

Candor Bioscience site in Germany.

Medix Biochemica, a supplier of critical raw materials for the in vitro diagnostics (IVD) industry, has acquired Candor Bioscience GmbH, a Germany-based developer and manufacturer of premium immunoassay solutions. The acquisition strengthens Medix Biochemica’s range of high-quality raw materials and enhances its capabilities to support test manufacturers in immunoassay development. Following the transaction, Candor Bioscience’s operations will remain in Germany. “We are delighted to welcom...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters